Regencell Bioscience Holdings Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/16/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNASDAQ

Market Capitalization4,958.84 mln

Float56.10 mln

Earnings Date10/28/2026

Business Description

Regencell Bioscience Holdings Limited is a Hong Kong-based company dedicated to advancing Traditional Chinese Medicine as a modern treatment option. Founded in 2014 and based in Causeway Bay, the company applies scientific research to develop and bring to market remedies targeting brain and cognitive conditions, with a particular focus on ADHD and autism spectrum disorder.

Key Fundamentals

EPS-0.02

ROE-165

ROIC-224

ROA-130

EBITDA, mln-7.01

EV / EBITDA-439

EV / EBIT-437

Quote Details

Last 9.59

Change 0.07 (0.74%)

Open 10.31

Volume 680,510

Turnover 6,526,091

Average Volume 298,305

Financial Ratios

Leverage Ratio1.10

Current Ratio1.42

Price / Book370

Debt / Equity0.32

Financial Strength

Piotroski F-Score 1 / 9

Short Ratio3.95

Short % of Float1.16

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	30.48%	100 / 100
1 Month	60.91%	100 / 100
2 Months	89.9%	100 / 100
6 Months	-66.55%	1 / 100
1 Year	-48.88%	5 / 100